Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations.
about
PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamicsCa(V)1.1: The atypical prototypical voltage-gated Ca²⁺ channelHeart and Skeletal Muscle Are Targets of Dengue Virus InfectionPharmGKB summary: very important pharmacogene information for RYR1Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicityAlteration of sarcoplasmic reticulum ca release in skeletal muscle from calpain 3-deficient mice.Ca2+ influx via the Na+/Ca2+ exchanger is enhanced in malignant hyperthermia skeletal muscle.A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.The cardiac alpha(1C) subunit can support excitation-triggered Ca2+ entry in dysgenic and dyspedic myotubesRGK protein-mediated impairment of slow depolarization- dependent Ca2+ entry into developing myotubes.Management of malignant hyperthermia: diagnosis and treatment.Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference.Malignant hyperthermia: a pharmacogenetic disorder.Identification of Leptospira interrogans phospholipase C as a novel virulence factor responsible for intracellular free calcium ion elevation during macrophage death.Alterations of excitation-contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscleTemperature and RyR1 regulate the activation rate of store-operated Ca²+ entry current in myotubesThe skeletal L-type Ca(2+) current is a major contributor to excitation-coupled Ca(2+) entry.Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle.Skeletal Muscle Microalterations in Patients Carrying Malignant Hyperthermia-Related Mutations of the e-c Coupling Machinery.The disorders of the calcium release unit of skeletal muscles: what have we learned from mouse models?Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.Divergent biophysical properties, gating mechanisms, and possible functions of the two skeletal muscle Ca(V)1.1 calcium channel splice variantsA focus on extracellular Ca2+ entry into skeletal muscle.Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.Calcium channel blockers are inadequate for malignant hyperthermia crisis.Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.[Telephone enquiries on the topic of malignant hyperthermia: Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig].With the greatest care, stromal interaction molecule (STIM) proteins verify what skeletal muscle is doing
P2860
Q26781824-8CEDA980-355D-45F3-833D-EE6ABC322C8BQ26866428-AD3E9D98-7ED4-477E-8ABC-73E80F63FBC7Q27491023-3A606FDA-B0E7-40F7-AD6C-AD7FA5ACE211Q28074804-309AAF44-4E17-4CC3-B726-D68D9CF1771AQ28393648-9D6FD295-2800-41C4-BF91-202CF216DDDCQ33726108-97195C75-FE3F-425E-AA3E-EEA5440ABF7BQ33846552-610835C8-DF5A-4C50-A0E7-826ACE2D3AB5Q33922807-07C2A9F3-15BC-41B1-8FC5-082CAB8EE8B9Q34080958-6C78E1C9-3D10-467A-ADA6-874D77457ACAQ34373988-E48B9216-BBBA-4D2B-8DA7-98F1EE5ADC71Q34421643-F6CB78D5-A533-4207-AE5D-DFE798F120A0Q34701056-9C68D10D-9A40-4F23-8C1E-E92D4C399DCDQ34770934-A5401878-223A-4053-A2BB-42DEF2DE1DD2Q34883560-BF0B0991-DF95-44B0-89CD-2763CA841BDBQ35016788-F18CF44A-25E1-4379-BDD8-7570D6ADA126Q35093498-EDCBCAE4-4444-4B87-A5FB-DCCBE8B9B38DQ36105323-3741D713-3095-462C-B9E6-8EFD8DF89DB9Q37023260-61CD3DC5-BF86-4747-990E-10F219A42FD9Q37305499-184DF3CC-59D8-4346-8310-5CEEBEA876E2Q37570836-69E80197-F629-46BD-9A96-8D5183748060Q38271367-177FC567-04AB-45DD-BDFE-D2E1BE02A0AAQ39493236-0BFA7124-B7E3-4010-8487-D4789B17BDC3Q42128833-2395B793-F082-4F89-9158-34AA99F77EF7Q42370439-ABEB490B-9195-4615-AD0A-A9A96D729397Q47253099-C9C915B9-F511-4D04-9EEB-8AC39E06D042Q48185387-360EAECA-DB58-4E68-AD03-8AD239DF326DQ50510755-4F9E4A46-27B6-4D2D-B19A-DBBE7A828FCCQ53306562-08DAB1AC-E4B8-4195-B659-7976F98D2C68Q58780464-06878D36-97B0-4BAA-86B6-7DC366F37984
P2860
Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Enhanced excitation-coupled ca ...... ignant hyperthermia mutations.
@en
Enhanced excitation-coupled ca ...... ignant hyperthermia mutations.
@nl
type
label
Enhanced excitation-coupled ca ...... ignant hyperthermia mutations.
@en
Enhanced excitation-coupled ca ...... ignant hyperthermia mutations.
@nl
prefLabel
Enhanced excitation-coupled ca ...... ignant hyperthermia mutations.
@en
Enhanced excitation-coupled ca ...... ignant hyperthermia mutations.
@nl
P2093
P2860
P356
P1476
Enhanced excitation-coupled ca ...... ignant hyperthermia mutations.
@en
P2093
Isaac N Pessah
Jose R Lopez
Paul D Allen
Tianzhong Yang
P2860
P304
37471-37478
P356
10.1074/JBC.M701379200
P407
P577
2007-10-16T00:00:00Z